Sivik Global Healthcare LLC
GREENWICH, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Oct 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$175.0M2026 Q3
Positions35
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.46.2%
What Changed This Quarter?
Top Holdings
XBI
SPDR Series
16.2%
HUM
Humana
3.9%
JNJ
Johnson & Johnson
3.6%
MRK
Merck
3.3%
ABBV
AbbVie
3.3%
TMO
Thermo Fisher Scientific
3.3%
CAH
Cardinal Health
3.2%
MCK
Mckesson
3.2%
New / Increased
12 new · 14 increased
CNCNEW
Centene
2.8%
RVTYNEW
Revvity
2.6%
BRKRNEW
Bruker
2.4%
MDTNEW
Medtronic
2.2%
RGENNEW
Repligen
2.2%
XBI
SPDR Series
16.2%
+20.0%
ELV
Elevance Health
3.1%
+180.0%
EHC
Encompass Health
2.8%
+166.7%
Reduced / Exited
5 reduced · 11 sold out
WAT
Waters
2.5%
-33.3%
LLY
Eli Lilly
2.8%
-15.4%
HUM
Humana
3.9%
-11.5%
BIO
Bio Rad Labs
1.7%
-20.0%
MTD
Mettler Toledo
2.2%
-9.1%
Call- Bsx 100…EXIT
Call- BSX 100
3.8%
ISRGEXIT
Intuitive Surg
3.2%
AZNEXIT
AstraZeneca
3.0%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.